Saturday, April 06, 2019 10:56:24 AM
The CNS group of LSRI invented and developed other ethical drugs, including the lead compound AF710B, for treatment of several CNS neurodegenerative diseases including Alzheimer’s disease. LSRI licensed the patent and rights to use to Anavex, USA which obtained orphan drug status for AF710B (AV-3-71) from the FDA for the treatment of frontotemporal dementia disease (FTD).
https://iibr.gov.il/Collaborate/Pages/LSRI.aspx
Anavex 3-71
https://www.karger.com/Article/Pdf/440864
https://iibr.gov.il/Research_Development/PatentsAndApplications/Pages/AF710B.aspx
Good luck and GOD bless,
